BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6262889)

  • 1. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Müller P; Kather H; Simon B
    Res Exp Med (Berl); 1981; 178(2):151-4. PubMed ID: 6262889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch.
    Daly MJ; Humphray JM; Bunce KT; Stables R
    Agents Actions; 1981 Apr; 11(1-2):160-4. PubMed ID: 6113743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
    Palacios B; Montero MJ; Sevilla MA; San Román L
    Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral ranitidine: onset and duration of action.
    Dammann HG; Müller P; Simon B
    Br J Anaesth; 1982 Nov; 54(11):1235-6. PubMed ID: 6128015
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man.
    Berstad A; Frislid K; Rydning A
    Scand J Gastroenterol; 1982 Jan; 17(1):109-12. PubMed ID: 6127787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of a new histamine H2 receptor agonist (impromidine) and antagonist (ranitidine).
    Pollock DM; Banks RO; Jacobson ED
    Pharmacol Res Commun; 1982 Jul; 14(7):605-12. PubMed ID: 6127724
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.
    Peden NR; Saunders JH; Wormsley KG
    Lancet; 1979 Mar; 1(8118):690-2. PubMed ID: 85934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
    Domschke W; Lux G; Domschke S
    Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin].
    Simon B; Bergdolt H; Dammann HG; Müller P
    Arzneimittelforschung; 1992 Feb; 42(2):133-5. PubMed ID: 1610422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
    Okabe S; Kawakami M
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the histamine-stimulated gastric secretion in healthy subjects by the H2-receptor antagonist ranitidine.
    Bohman T; Myren J; Larsen S
    Scand J Gastroenterol; 1980; 15(2):183-9. PubMed ID: 6104354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.